Search - tctmd.com

Displaying 541 - 560 of 3107

Sort: Relevancy | Date

Presentation THT Abstracts 2024

The Impact of Preoperative Impella Support on Left Ventricular Assist Device Survival and Quality of Life

Presenter: Timothy George

March 04, 2024

Presentation THT 2024

Anterior Scar Exclusion Using the BioVentrix Revivent System

Presenter: Jerry D. Estep

March 04, 2024

Presentation THT 2024

Cardiac Recovery in Response to GDMT

Presenter: Andreas Kalogeropoulos

March 04, 2024

Presentation THT 2024

LV Restoration: The Physics of Physical Reverse Remodeling

Presenter: Randall C. Starling

March 04, 2024

Presentation THT 2024

Myocardial Recovery at the Level of the Single Myocyte

Presenter: Veli K. Topkara

March 04, 2024

Presentation THT 2024

LV Restoration: The Biology of Biological Reverse Myocardial Remodeling and Recovery

Presenter: Douglas L. Mann

March 04, 2024

Presentation THT 2024

Current Understanding of the Incidence, Characteristics, and Sustainability of "Recoverers" in Response to LVAD Support

Presenter: Emma Birks

March 04, 2024

Presentation THT 2024

A Heart Team Approach to Management of TR in Patients With Cardiac Implantable Electronic Device Leads (CEIDs)

Presenter: Rebecca T. Hahn

March 04, 2024

Presentation THT 2024

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

Presenter: Sean P. Pinney

March 04, 2024

Presentation THT 2024

The TMVR Landscape: Second Generation Devices and Clinical Trial Pathways

Presenter: Martin B. Leon

March 04, 2024

Presentation THT 2024

Reducing Congestion by Removing Fluid From the Interstitium

Presenter: William T. Abraham

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Presenter: Ulrich P. Jorde

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Presenter: Jennifer A. Cowger

March 04, 2024

Presentation THT 2024

Biomarkers of Congestion: Utility in Clinical Practice and Clinical Trials

Presenter: James Januzzi

March 04, 2024

Presentation THT 2024

Mechanisms of Diuretic Resistance

Presenter: Jeffrey Testani

March 04, 2024

Presentation THT 2024

Contemporary Pharmacological Therapies for Acute Heart Failure

Presenter: Wilfried Mullens

March 04, 2024

Presentation THT 2024

Left-to-Right Shunting for Chronic Heart Failure: Overview of the Device Landscape

Presenter: Benjamin Hibbert

March 04, 2024

Presentation THT 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presenter: Michael R. Zile

March 04, 2024

Presentation THT 2024

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Presentation Miami Valves 2024

New Devices For Left Atrial Appendage Closure

Presenter: Saibal Kar

February 03, 2024

Advertisement

The Impact of Preoperative Impella Support on Left Ventricular Assist Device Survival and Quality of Life

Anterior Scar Exclusion Using the BioVentrix Revivent System

Cardiac Recovery in Response to GDMT

LV Restoration: The Physics of Physical Reverse Remodeling

Myocardial Recovery at the Level of the Single Myocyte

LV Restoration: The Biology of Biological Reverse Myocardial Remodeling and Recovery

Current Understanding of the Incidence, Characteristics, and Sustainability of "Recoverers" in Response to LVAD Support

A Heart Team Approach to Management of TR in Patients With Cardiac Implantable Electronic Device Leads (CEIDs)

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

The TMVR Landscape: Second Generation Devices and Clinical Trial Pathways

Reducing Congestion by Removing Fluid From the Interstitium

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Biomarkers of Congestion: Utility in Clinical Practice and Clinical Trials

Mechanisms of Diuretic Resistance

Contemporary Pharmacological Therapies for Acute Heart Failure

Left-to-Right Shunting for Chronic Heart Failure: Overview of the Device Landscape

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

New Devices For Left Atrial Appendage Closure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content